Patents by Inventor Colin Louis Masters

Colin Louis Masters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
    Publication number: 20110071167
    Abstract: The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or otherwise treating or ameliorating the symptoms of, age-related macular degeneration (AMD) or related retinal conditions in mammals and in particular humans. The present invention further provides therapeutic compositions enabling dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions.
    Type: Application
    Filed: November 23, 2010
    Publication date: March 24, 2011
    Applicant: PRANA BIOTECHNOLOGY LIMITED
    Inventors: Ashley BUSH, Colin Louis MASTERS, Penelope Jane HUGGINS, Jack Gordon PARSONS, Gaik Beng KOK, Vijaya KENCHE, Mariana EL SOUS
  • METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
    Publication number: 20100144693
    Abstract: The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or otherwise treating or ameliorating the symptoms of, age-related macular degeneration (AMD) or related retinal conditions in mammals and in particular humans. The present invention further provides therapeutic compositions enabling dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions.
    Type: Application
    Filed: April 13, 2007
    Publication date: June 10, 2010
    Applicant: PRANA BIOTECHNOLOGY LIMITED
    Inventors: Ashley Bush, Colin Louis Masters, Penelope Jane Huggins, Jack Gordon Parsons, Gaik Beng Kok, Vijaya Kenche, Mariana El Sous
  • Method for treating Alzheimer's disease
    Publication number: 20040265847
    Abstract: The present invention is directed to methods for treating Alzheimer's Disease by modulating divalent cation, trivalent cation and/or heparin interaction with amyloid precursor protein (APP). In particular, the present invention is directed to methods for treating Alzheimer's Disease by administering to a patient with Alzheimer's Disease a therapeutically effective amount of a zinc binding agent for modulating the interaction of zinc and/or heparin with APP and thereby preventing the aberrant processing of APP.
    Type: Application
    Filed: November 19, 2003
    Publication date: December 30, 2004
    Inventors: Colin Louis Masters, Ashley Ian Bush, Konrad Traugott Beyreuther
  • Promoter of the gene for the human precursor of the alzheimer's disease and its use
    Patent number: 5853985
    Abstract: The present invention is related to the promoter of the gene for the human precursor of the Alzheimer's Disease A4 amyloid protein (PAD gene). Another object of the present invention is the use of this promoter in a method of establishing a screening model for the Alzheimer's Disease. Thus, the present invention is also related to a vector useful in the transfection of cells and the cells and animals transfected therewith.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 29, 1998
    Assignee: Bayer Aktiegsesellschaft
    Inventors: Johannes Michael Hermann Salbaum, Colin Louis Masters, Konrad Traugott Beyreuter
  • Method of assaying for alzheimer's disease
    Patent number: 5705401
    Abstract: The present invention relates to a method of assaying for Alzheimer's disease in a human by determining the relative abundance of one or more forms of amyloid precursor protein (APP) or the enzyme responsible for said forms in circulatory fluid and to a method for treating the disease by modulating divalent cation, trivalent cation and/or heparin interaction with APP.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: January 6, 1998
    Assignee: The University of Melbourne
    Inventors: Colin Louis Masters, Ashley Ian Bush, Konrad Traugott Beyreuther